Diarrhea News and Research

Latest Diarrhea News and Research

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

AMAG updates product label of Feraheme Injection

AMAG updates product label of Feraheme Injection

Immunity-enhancing probiotics may be the best line of defense for good health

Immunity-enhancing probiotics may be the best line of defense for good health

Specialists suggest U.S. should stockpile cholera vaccines for rapid deployment at disease outbreak

Specialists suggest U.S. should stockpile cholera vaccines for rapid deployment at disease outbreak

Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA

Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA

Vertex submits NDA for telaprevir for treating hepatitis C

Vertex submits NDA for telaprevir for treating hepatitis C

Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

Arthritis Foundation, Covidien join forces to help Americans suffering from osteoarthritis

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Pfizer's Phase 3 AXIS 1032 trial for metastatic renal cell carcinoma meets primary endpoint

Merck wins third FOSAMAX bellwether trial

Merck wins third FOSAMAX bellwether trial

U.S. falling short of its goals to improve access to clean water, sanitation worldwide, report says

U.S. falling short of its goals to improve access to clean water, sanitation worldwide, report says

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

Cholera confirmed in Florida woman who traveled to Haiti

Cholera confirmed in Florida woman who traveled to Haiti

Aeterna presents data on AEZS-108 Phase 2 study for endometrial cancer at EORTC-NCI-AACR Symposium

Aeterna presents data on AEZS-108 Phase 2 study for endometrial cancer at EORTC-NCI-AACR Symposium

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Exelixis reports interim data from phase 2 RDT trial for epithelial ovarian cancer

Viruses lead to discovery of security system in host cells

Viruses lead to discovery of security system in host cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.